Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Albireo Pharma Inc banner
A

Albireo Pharma Inc
F:BDQM

Watchlist Manager
Albireo Pharma Inc
F:BDQM
Watchlist
Price: 41.41 EUR 0.46% Market Closed
Market Cap: €857.2m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+87%
5Y
+317%
10Y
-
Liabilities
+
3Y
+217%
5Y
+2 664%
10Y
-
Equity
+
3Y
-2%
5Y
+45%
10Y
-

Balance Sheet Decomposition
Albireo Pharma Inc

Balance Sheet
Albireo Pharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
30
53
164
132
251
248
Cash Equivalents
30
53
164
132
251
248
Total Receivables
0
1
3
0
0
3
Accounts Receivables
0
0
0
0
0
3
Other Receivables
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
Other Current Assets
1
1
1
10
11
17
Total Current Assets
31
55
168
142
262
269
PP&E Net
0
0
0
5
5
13
PP&E Gross
0
0
0
5
5
13
Accumulated Depreciation
0
0
0
0
0
1
Intangible Assets
0
0
0
0
0
0
Goodwill
18
17
17
17
17
17
Other Long-Term Assets
1
1
0
1
2
3
Other Assets
18
17
17
17
17
17
Total Assets
50
N/A
73
+47%
186
+153%
165
-11%
286
+73%
302
+6%
Liabilities
Accounts Payable
1
1
4
5
5
7
Accrued Liabilities
8
6
8
14
20
37
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
0
0
0
0
0
Other Current Liabilities
1
1
0
0
0
1
Total Current Liabilities
13
8
13
19
25
45
Long-Term Debt
0
0
0
0
10
10
Other Liabilities
0
0
50
53
70
71
Total Liabilities
13
N/A
8
-37%
63
+685%
72
+14%
104
+45%
126
+21%
Equity
Common Stock
0
0
0
0
0
0
Retained Earnings
26
50
97
159
267
301
Additional Paid In Capital
61
115
215
246
457
475
Treasury Stock
0
0
0
0
0
0
Other Equity
2
1
4
7
9
1
Total Equity
37
N/A
65
+76%
123
+88%
93
-24%
181
+94%
176
-3%
Total Liabilities & Equity
50
N/A
73
+47%
186
+153%
165
-11%
286
+73%
302
+6%
Shares Outstanding
Common Shares Outstanding
6
9
12
13
19
19
Preferred Shares Outstanding
0
0
0
0
0
0

See Also

Summary
BDQM intrinsic value, competitors valuation, and company profile.
DCF Valuation
BDQM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BDQM stock valuation using valuation multiples.
Wall Street Estimates
BDQM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BDQM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.